Published Sep 20, 2026
Pharvaris (PHVS): Dual Oral Wins Recast an Angioedema Franchise
In-depth research on PHVS covering the business overview, key financial moves, risk frame, and the bottom-line on what changed since the last report.
3,387 words15 min read
Read report